A Randomized Controlled Trial of Port Site Subcutaneous Injection of Bupivacaine to Determine the Effectiveness of Postoperative Pain Relief After Laparoscopic Cholecystectomy
Overview
- Phase
- Phase 3
- Intervention
- 0.25% Bupivacaine
- Conditions
- Pain, Postoperative
- Sponsor
- Hamdard University
- Enrollment
- 166
- Primary Endpoint
- Post laparoscopic port site pain assessment
- Last Updated
- 4 years ago
Overview
Brief Summary
To determine the effectiveness of port site bupivacaine infiltration in postoperative pain reduction after laparoscopic cholecystectomy.
Detailed Description
The study is being done to determine the effectiveness of port site bupivacaine infiltration in postoperative pain reduction after laparoscopic cholecystectomy.
Investigators
Dr. Nida Shahid
Assistant Professor
Hamdard University
Eligibility Criteria
Inclusion Criteria
- •Patients of both the gender of age \>18 years and \<45years
- •Patients undergoing elective laparoscopic cholecystectomy under general anesthesia.
- •Patients with A.S.A grade I and II.
Exclusion Criteria
- •Patients with known allergic reactions to local anesthetics.
- •Patients converted to open procedure.
- •Patients developing intra-operative complications.
- •Patients undergoing for laparoscopic cholecystectomy for acute cholecystitis.
- •Patients with obesity and chronic illness.
- •Patients with history of opioids, steroids, NSAIDs and alcohol use.
Arms & Interventions
Bupivacaine group
Patient receiving 20ml of inj. 0.25% Bupivacaine at laparoscopic port site
Intervention: 0.25% Bupivacaine
Outcomes
Primary Outcomes
Post laparoscopic port site pain assessment
Time Frame: Pain assessment from 0hour (patient received in recovery room) till 12hours postoperatively at interval of 3hours i.e. 0,3,6,9,12 hour
Pain assessment by "Visual Analog Scoring system" scoring from 0 to 10, where 0 means no pain and 10 means worst possible, unbearable excruciating pain.